IL6 and COVID-19: van Daal et al. demonstrated that desmosine and isodesmosine (DES), two biomarkers for elastin degradation, increase in COVID-19 patients and DES levels correlated with the amount of IL-6, suggesting a key link between inflammation and pulmonary/vascular tissue damage in COVID-19 [32].